The Choline/Creatine Ratio in Five Benign Neoplasms: Comparison with Squamous Cell Carcinoma by Use of in Vitro MR Spectroscopy
Shailendra R. Maheshwaria,
Suresh K. Mukherjia,b,
Brian Neelona,
Sharon Schiroa,
Girish M. Fatterpekara,
Jeffrey A. Stonea and
Mauricio Castilloa
a From the Departments of Radiology (S.R.M., S.K.M., S.S., G.M.F., J.A.S., M.C.), Surgery (S.K.M.), and Anesthesiology (S.K.M.), and the Lineberger Comprehensive Cancer Center (S.K.M., B.N.), University of North Carolina, Chapel Hill.
b Address reprint requests to Suresh K. Mukherji, MD, Department of Radiology, 3324 Old Infirmary, CB# 7510, University of North Carolina School of Medicine, Chapel Hill, NC 27599.

View larger version (15K):
[in a new window]
|
FIG 1. Inverting papilloma. In vitro 1D proton MR spectrum (2000/136/128) shows elevation of the Cho/Cr ratio. Curved arrow indicates Cho; straight arrow, Cr
| |

View larger version (10K):
[in a new window]
|
FIG 2. Glomus tumor. In vitro 1D proton MR spectrum (2000/136/128) shows elevation of the Cho/Cr ratio. Curved arrow indicates Cho; straight arrow, Cr
| |

View larger version (11K):
[in a new window]
|
FIG 3. Vagal schwannoma. In vitro 1D proton MR spectrum (2000/136/128) shows elevation of the Cho/Cr ratio. Curved arrow indicates Cho; straight arrow, shoulder of Cr resonance
| |

View larger version (9K):
[in a new window]
|
FIG 4. Strap muscle. In vitro 1D proton MR spectrum (2000/136/128) shows similar areas of the Cho/Cr ratio. Curved arrow indicates Cho; straight arrow, Cr
| |

View larger version (10K):
[in a new window]
|
FIG 5. SCCA. In vitro 1D proton MR spectrum (2000/136/128) of SCCA obtained from the same patient as in figure 3 shows elevation of the Cho/Cr ratio. Curved arrow indicates Cho; straight arrow, Cr
| |